Page last updated: 2024-08-26

fotemustine and Anemia

fotemustine has been researched along with Anemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baruchel, S; Bouffet, E; Gammon, J; Grant, RM; Hargrave, DR; Tariq, N	1
Allen, R; Berille, J; Rudd, R; Souhami, RL; Spiro, SG; Trask, C	1
Boaziz, C; Coste, M; Haon, C; Raymond, E	1
Ascierto, PA; Cellerino, R; Comella, G; Comella, P; Daponte, A; DeLena, M; Gravina, A; Marini, G; Melucci, MT; Palmieri, G	1

Reviews

1 review(s) available for fotemustine and Anemia

Article	Year
Logistic regression model of fotemustine toxicity combining independent phase II studies. Cancer, 1996, Nov-01, Volume: 78, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Female; Humans; Leukopenia; Logistic Models; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia	1996

Article

Year

Logistic regression model of fotemustine toxicity combining independent phase II studies.

Cancer, 1996, Nov-01, Volume: 78, Issue:9

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Female; Humans; Leukopenia; Logistic Models; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia

1996

Trials

3 trial(s) available for fotemustine and Anemia

Article	Year
Phase I study of fotemustine in pediatric patients with refractory brain tumors. Cancer, 2002, Sep-15, Volume: 95, Issue:6 Topics: Adolescent; Anemia; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Ependymoma; Female; Humans; Infant; Injections, Intravenous; Male; Medulloblastoma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Sarcoma; Thrombocytopenia; Treatment Outcome	2002
Phase II study of fotemustine in untreated inoperable non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:5 Topics: Aged; Anemia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Quality of Life; Thrombocytopenia	1994
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group. Cancer, 2000, Dec-15, Volume: 89, Issue:12 Topics: Adult; Aged; Anemia; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; CD146 Antigen; Cisplatin; Dacarbazine; Female; Fever; Follow-Up Studies; Humans; Interferon-alpha; Male; MART-1 Antigen; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nausea; Neoplasm Proteins; Neural Cell Adhesion Molecules; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting	2000